Literature DB >> 3312008

Serological relationships between Escherichia coli and Salmonella smooth- and rough-mutant lipopolysaccharides as revealed by enzyme-linked immunosorbent assay for human immunoglobulin G antiendotoxin antibodies.

G R Barclay1, B B Scott.   

Abstract

Reactions of sera from healthy blood donors to smooth and rough mutant lipopolysaccharides (LPS) from Escherichia coli O111:B4 and Salmonella minnesota which had been complexed with polymyxin B were determined by enzyme-linked immunosorbent assay. Relative enzyme-linked immunosorbent assay reactivities were examined for prima facie evidence of cross-reactivity by analyses of correlation and relative scatter. Patterns of reactivity were interpreted in relation to published structures. Evidence was obtained for two dominant epitopes associated with the lipid A-2-keto-3-deoxyoctulosonic acid and heptose regions of the LPS core. Sera demonstrated apparent exclusive antibody homogeneity in that given sera showed only one of the two possible specificities, which occurred with equal frequency. Cross-reactivity was found in the lipid A-2-keto-3-deoxyoctulosonic acid region for all LPS. Cross-reactivity was found in the heptose region for larger rough mutant S. minnesota LPS and smooth S. minnesota LPS and for E. coli O111:B4 LPS but not for E. coli rough mutant J5 LPS, whose heptose region appears to be different from those of the other organisms.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3312008      PMCID: PMC259965          DOI: 10.1128/iai.55.11.2706-2714.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  THE BIOSYNTHESIS OF CELL WALL LIPOPOLYSACCHARIDE IN ESCHERICHIA COLI. I. THE BIOCHEMICAL PROPERTIES OF A URIDINE DIPHOSPHATE GALACTOSE 4-EPIMERASELESS MUTANT.

Authors:  A D ELBEIN; E C HEATH
Journal:  J Biol Chem       Date:  1965-05       Impact factor: 5.157

2.  Interaction of divalent cations and polymyxin B with lipopolysaccharide.

Authors:  M Schindler; M J Osborn
Journal:  Biochemistry       Date:  1979-10-02       Impact factor: 3.162

3.  Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides.

Authors:  D C Morrison; D M Jacobs
Journal:  Immunochemistry       Date:  1976-10

4.  Incorporation of N-acetylglucosamine into the core region of the cell wall lipopolysaccharide of Escherichia coli.

Authors:  R Stein; E C Heath
Journal:  J Biol Chem       Date:  1979-05-25       Impact factor: 5.157

5.  The biosynthesis of cell wall lipopolysaccharide in Escherichia coli. VII. Characterization of heterogeneous "core" oligosaccharide structures.

Authors:  N A Fuller; M Wu; R G Wilkinson; E C Heath
Journal:  J Biol Chem       Date:  1973-11-25       Impact factor: 5.157

6.  Type-specific and cross-reactive antibodies in gram-negative bacteremia.

Authors:  W R McCabe; B E Kreger; M Johns
Journal:  N Engl J Med       Date:  1972-08-10       Impact factor: 91.245

Review 7.  Infections due to gram-negative organisms: an analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958-1966.

Authors:  H L DuPont; W W Spink
Journal:  Medicine (Baltimore)       Date:  1969-07       Impact factor: 1.889

8.  Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures.

Authors:  D C Morrison; L Leive
Journal:  J Biol Chem       Date:  1975-04-25       Impact factor: 5.157

Review 9.  Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients.

Authors:  B E Kreger; D E Craven; P C Carling; W R McCabe
Journal:  Am J Med       Date:  1980-03       Impact factor: 4.965

10.  Controlled trial of Pseudomonas immunoglobulin and vaccine in burn patients.

Authors:  R J Jones; E A Roe; J L Gupta
Journal:  Lancet       Date:  1980-12-13       Impact factor: 79.321

View more
  17 in total

Review 1.  Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides.

Authors:  I G Mitov; D G Terziiski
Journal:  Infection       Date:  1991 Nov-Dec       Impact factor: 3.553

2.  Association of SIGNR1 with TLR4-MD-2 enhances signal transduction by recognition of LPS in gram-negative bacteria.

Authors:  Koji Nagaoka; Kazuhiko Takahara; Kay Tanaka; Hideo Yoshida; Ralph M Steinman; Shin-Ichiro Saitoh; Sachiko Akashi-Takamura; Kensuke Miyake; Young Sun Kang; Chae Gyu Park; Kayo Inaba
Journal:  Int Immunol       Date:  2005-05-20       Impact factor: 4.823

3.  Serum immunoglobulins to endotoxin core glycolipid: establishment of normal concentrations.

Authors:  S K Jackson; J Parton; G Shortland; J M Stark; E N Thompson
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

4.  Natural human antibodies to pneumococcus have distinctive molecular characteristics and protect against pneumococcal disease.

Authors:  H E Baxendale; M Johnson; R C M Stephens; J Yuste; N Klein; J S Brown; D Goldblatt
Journal:  Clin Exp Immunol       Date:  2007-11-05       Impact factor: 4.330

5.  Significance of systemic endotoxaemia in inflammatory bowel disease.

Authors:  K R Gardiner; M I Halliday; G R Barclay; L Milne; D Brown; S Stephens; R J Maxwell; B J Rowlands
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

6.  Differential induction of tumor necrosis factor by bacteria expressing rough and smooth lipopolysaccharide phenotypes.

Authors:  N M Kelly; L Young; A S Cross
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

7.  Cross-reactivity of monoclonal antibodies and sera directed against lipid A and lipopolysaccharides.

Authors:  H M Kuhn
Journal:  Infection       Date:  1993 May-Jun       Impact factor: 3.553

8.  Sequential anti-core glycolipid immunoglobulin antibody activities in patients with and without septic shock and their relation to outcome.

Authors:  M Nys; P Damas; L Joassin; M Lamy
Journal:  Ann Surg       Date:  1993-03       Impact factor: 12.969

9.  Intestinal hypoperfusion contributes to gut barrier failure in severe acute pancreatitis.

Authors:  Sakhawat H Rahman; Basil J Ammori; John Holmfield; Michael Larvin; Michael J McMahon
Journal:  J Gastrointest Surg       Date:  2003-01       Impact factor: 3.452

10.  Antibodies to endotoxin core in sudden infant death syndrome.

Authors:  B A Oppenheim; G R Barclay; J Morris; F Knox; A Barson; D B Drucker; B A Crawley; J A Morris
Journal:  Arch Dis Child       Date:  1994-02       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.